AI Harms in Healthcare: Who is Liable?

---

LIVEDHPAMAFace to Face

Thursday, February 12, 2026, 8:30 AM - 3:00 PM, Hilton, West Bay, Diplomatic St., Doha, Qatar

When AI goes wrong in healthcare, who takes the blame—doctor, hospital, or developer? This session unpacks case studies, compares global approaches, and highlights practical steps to share responsibility fairly. Participants will leave with an understanding of laws, policies and questions to consider—designed to protect patients, reduce risk, and support safe innovation where AI is used in practice.

1. Analyze doctor liability with AI clinical decision-making
2. Evaluate hospital liability for integrating AI systems
3. Identify developer liability regarding AI biases and regulations
4. Compare global legal standards for AI liability
5. Choose guidelines for clarifying AI liability roles

Early bird rate until January 15, 2026 QAR 137 ; USD 37.50

Regular fees starting January 16, 2026 QAR 182 ; USD 50

Changes or Cancellations

1- Name changes or substitutions are not permitted.
2- All cancellation and refund requests must be made in writing and submitted via email to [email protected].
3- For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
4- We will attempt to process the refund within 30 days of receiving any cancellation request.
5- Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to [email protected]..

DHP 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 4.50 hours.

ACCME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Weill Cornell Medicine-Qatar and Hamad Bin Khalifa University.

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this Live Activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Mark Santos, RN, Melissa Toon, OT, Kadhija Vamanjoor, BDS, Phyllis Muffuh Navti, DHSci, Deema Al-Sheikhly, MRes, MEHP

Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Directors: Thurayya Arayssi, MD, Barry Solaiman, PhD

Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty - Mohammed Ghaly, PhD, Barry Solaiman, PhD, Thurayya Arayssi, MD

Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty: Sara Gerke, JD

Disclosed the following financial relationship:
Grant or research support - EU grants ; Consulting fees - University of Copenhagen Inter-Cebil Novo Nordisk Foundation; Grants or research support - Cancer center at Illinois; Granst or research support - NIBIB 5R21EB035474-02

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty - Paul Campbell, MBChB, MRPharmS, FRCA, EMBA

Disclosed the following financial relationship:

Employment - HealthAI ; Advisor - valkit.ai

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated
Will not be discussing unlabeled/unapproved use of drugs or products

Administrative Contact: Ameena Abdul Rahim, MSc

Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Thursday, February 12, 2026